Syntiron

About:

Syntiron’s antigen discovery and purification technology targets the bacterial iron transport proteins that are critical for causing.

Website: http://syntiron.com/

Top Investors: CARB-X

Description:

Syntiron’s antigen discovery and purification technology targets the bacterial iron transport proteins that are critical for causing an infection.

Total Funding Amount:

$1.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Saint Paul, Minnesota, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)syntiron.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-01-18

IPO Status:

Private

Industries: